FDA has decided at least 60 million doses of Johnson & Johnson’s coronavirus vaccine must be be discarded; 10 million can be released

Peter Marks, director of the agency’s Center for Biologics Evaluation and Research, said in the statement, “These actions followed an extensive review of records, including the production history of the facility and the testing performed to evaluate the quality of the product. This review has been taking place while Emergent BioSolutions prepares to resume manufacturing operations with corrective actions to ensure compliance with the FDA’s current good manufacturing practice requirements.”

View original article here Source

Related Posts